Movers

Posted on: Tuesday, November 4, 2025 - 1:15pm

Energy Fuels Inc (AMEX:UUUU) shares are trading lower Tuesday after the company reported mixed third-quarter results.

All terms: Earnings, Earnings Misses, News, Movers

Posted on: Tuesday, November 4, 2025 - 1:15pm

Wingstop (NASDAQ: WING) shares surge on mixed Q3 results, with earnings beating expectations while revenue falls short.

All terms: Earnings, Earnings Beats, News, Guidance, Top Stories, Movers

Posted on: Tuesday, November 4, 2025 - 1:15pm

Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its outlook.

Posted on: Tuesday, November 4, 2025 - 12:58pm

Hertz shares blasted 40% higher Tuesday in an apparent short-squeeze following the company's Q3 earnings release.

All terms: Earnings, News, Movers, Trading Ideas

Posted on: Tuesday, November 4, 2025 - 12:56pm

Henry Schein tops Q3 earnings and revenue estimates, boosts 2025 outlook, and expands partnership with KKR amid strong dental and tech sales growth.

Posted on: Tuesday, November 4, 2025 - 12:45pm

Thomson Reuters reports Q3 2025 results with revenue of $1.78B, up 3% from last year. Adjusted EPS rose 6% and operating profit increased 43%.

All terms: Earnings, News, Guidance, Movers, Media, Trading Ideas

Posted on: Tuesday, November 4, 2025 - 12:41pm

CrowdStrike shares dipped. BTIG hiked its target and the company launched a Europe-wide, multilingual support program to expand Falcon adoption.

All terms: Equities, News, Markets, Movers

Posted on: Tuesday, November 4, 2025 - 12:37pm

All terms: News, Intraday Update, Markets, Movers, Trading Ideas

Posted on: Tuesday, November 4, 2025 - 12:34pm

Marriott shares jumped after a Q3 beat, record pipeline growth, and higher fees, though the company trimmed its guidance.

All terms: Earnings, News, Guidance, Top Stories, Movers

Posted on: Tuesday, November 4, 2025 - 12:33pm

Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.